Research informatics company Flywheel and data analysis software provider Imbio have partnered to accelerate researchers' understanding of COVID-19 and potential treatments.
Flywheel, Imbio, and their parent company, Invenshure, have decided to combine technologies to offer researchers powerful tools to aggregate and analyze COVID-19 data.
Beginning March 30, Flywheel's platform, including Imbio's lung analysis tools, will be available for free to COVID-19 academic and clinical researchers. More details will be announced soon.